THE BODY MASS INDEX INFLUENCES THE ACHIEVEMENT RATIO OF TARGET BLOOD PRESSURE BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN JAPANESE TYPE 2 DIABETES PATIENTS WITH CKD

被引：0
|
作者：
Kobayashi, Kazuo [1 ]
Tamura, Kouichi [2 ]
Toyoda, Masao [3 ]
Sakai, Hiroyuki [1 ]
Furuki, Takayuki [1 ]
Hatori, Nobuo [1 ]
Sato, Kazuyoshi [1 ]
Miyakawa, Masaaki [1 ]
Kanamori, Akira [1 ]
机构：
[1] Kanagawa Physicians Assoc, Comm Hypertens & Kidney Dis, Yokohama, Kanagawa, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Dept Internal Med, Isehara, Kanagawa, Japan
来源：
JOURNAL OF HYPERTENSION | 2021年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E211 / E211
页数：1
相关论文
共 50 条
  • [31] Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors
    Kim, Hun-Sung
    Lee, Eun Young
    Yoon, Kun-Ho
    DIABETES, 2018, 67
  • [32] Considerations and possibilities for sodium-glucose cotransporter 2 inhibitors in pediatric CKD
    Alexander J. Kula
    Pediatric Nephrology, 2022, 37 : 2267 - 2276
  • [33] Safety of sodium-glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
    Davidson, Jaime A.
    Sukor, Norlela
    Hew, Fen-Lee
    Mohamed, Mafauzy
    Hussein, Zanariah
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (02) : 167 - 182
  • [34] Sodium-glucose cotransporter-2 inhibitors and fractures in type 2 diabetes mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2022, 18 (02): : 198 - 199
  • [35] Clinical potential of sodium-glucose cotransporter 2 inhibitors in the management of type 2 diabetes
    Kim, Yoojin
    Babu, Ambika R.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2012, 5 : 313 - 327
  • [36] Sodium-glucose cotransporter 2 inhibitors and death and heart failure in type 2 diabetes
    Yanai, Hidekatsu
    ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (23)
  • [37] The gender gap in prescription pattern of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes
    Hammer, A.
    Hofer, F.
    Kazem, N.
    Koller, L.
    Steinacher, E.
    Niessner, A.
    Sulzgruber, P.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2691 - 2691
  • [38] Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering
    Neuen, Brendon L.
    Cherney, David Z.
    Jardine, Meg J.
    Perkovic, Vlado
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (41) : E1128 - E1135
  • [39] Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
    Xie, Yan
    Bowe, Benjamin
    Gibson, Andrew K.
    McGill, Janet B.
    Maddukuri, Geetha
    Al-Aly, Ziyad
    JAMA INTERNAL MEDICINE, 2021, 181 (08) : 1043 - 1053
  • [40] Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes
    Goldberg, David
    JAMA INTERNAL MEDICINE, 2022, 182 (01) : 93 - 93
12345